DE122008000031I1 - 8-Chlor-11-[1-[(5-methyl-3-pyridyl)-methyl]-4-piperidyliden]-6,11-dihydro-5H-benzol[5,6]cyclohepta[1,2-b]-pyridin - Google Patents
8-Chlor-11-[1-[(5-methyl-3-pyridyl)-methyl]-4-piperidyliden]-6,11-dihydro-5H-benzol[5,6]cyclohepta[1,2-b]-pyridinInfo
- Publication number
- DE122008000031I1 DE122008000031I1 DE122008000031C DE122008000031C DE122008000031I1 DE 122008000031 I1 DE122008000031 I1 DE 122008000031I1 DE 122008000031 C DE122008000031 C DE 122008000031C DE 122008000031 C DE122008000031 C DE 122008000031C DE 122008000031 I1 DE122008000031 I1 DE 122008000031I1
- Authority
- DE
- Germany
- Prior art keywords
- methyl
- cyclohepta
- pyridyl
- pyridine
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES09201054A ES2042421B1 (es) | 1992-05-22 | 1992-05-22 | Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina. |
DE69300255T DE69300255T2 (de) | 1992-05-22 | 1993-05-19 | 8-Chlor-11-(1-(5-methyl-3-pyridyl)methyl-4-piperidyliden)-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)-pyridin. |
Publications (2)
Publication Number | Publication Date |
---|---|
DE122008000031I1 true DE122008000031I1 (de) | 2008-10-02 |
DE122008000031I2 DE122008000031I2 (de) | 2010-12-30 |
Family
ID=8277082
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE122008000031C Active DE122008000031I2 (de) | 1992-05-22 | 1993-05-19 | 8-Chlor-11-[1-[(5-methyl-3-pyridyl)-methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]-pyridin |
DE69300255T Expired - Lifetime DE69300255T2 (de) | 1992-05-22 | 1993-05-19 | 8-Chlor-11-(1-(5-methyl-3-pyridyl)methyl-4-piperidyliden)-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)-pyridin. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69300255T Expired - Lifetime DE69300255T2 (de) | 1992-05-22 | 1993-05-19 | 8-Chlor-11-(1-(5-methyl-3-pyridyl)methyl-4-piperidyliden)-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)-pyridin. |
Country Status (13)
Country | Link |
---|---|
US (2) | US5407941A (de) |
EP (1) | EP0577957B1 (de) |
JP (1) | JP2730612B2 (de) |
KR (1) | KR0156518B1 (de) |
AT (1) | ATE124939T1 (de) |
CA (1) | CA2096318C (de) |
DE (2) | DE122008000031I2 (de) |
DK (1) | DK0577957T3 (de) |
ES (2) | ES2042421B1 (de) |
HK (1) | HK1006169A1 (de) |
LU (1) | LU91121I2 (de) |
MX (1) | MX9302958A (de) |
NL (1) | NL300384I2 (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571821A (en) * | 1993-05-20 | 1996-11-05 | Texas Biotechnology Corporation | Sulfonamides and derivatives thereof that modulate the activity of endothelin |
US5514691A (en) * | 1993-05-20 | 1996-05-07 | Immunopharmaceutics, Inc. | N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US5591761A (en) * | 1993-05-20 | 1997-01-07 | Texas Biotechnology Corporation | Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US5594021A (en) * | 1993-05-20 | 1997-01-14 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin |
US5962490A (en) | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
FI941826A (fi) * | 1993-04-21 | 1994-10-22 | Takeda Chemical Industries Ltd | Menetelmät ja koostumukset elimen hypofunktion ennaltaehkäisemiseksi ja/tai terapeuttiseksi hoitamiseksi |
US6030991A (en) * | 1993-05-20 | 2000-02-29 | Texas Biotechnology Corp. | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
US6342610B2 (en) | 1993-05-20 | 2002-01-29 | Texas Biotechnology Corp. | N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US6613804B2 (en) | 1993-05-20 | 2003-09-02 | Encysive Pharmaceuticals, Inc. | Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
ES2087818B1 (es) * | 1993-11-24 | 1997-03-16 | Uriach & Cia Sa J | 8-cloro-11-(1-((5-metil-3-piridil)metil)-4-piperidiliden)-6,11-dihidro-5h-benzo-(5,6)cicloheptal(1,2-b)piridina, fumarato. |
JP3779349B2 (ja) * | 1995-04-24 | 2006-05-24 | 興和株式会社 | ピペリジン誘導体 |
US5977117A (en) | 1996-01-05 | 1999-11-02 | Texas Biotechnology Corporation | Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin |
US5958905A (en) * | 1996-03-26 | 1999-09-28 | Texas Biotechnology Corporation | Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin |
US5804585A (en) | 1996-04-15 | 1998-09-08 | Texas Biotechnology Corporation | Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
ES2120899B1 (es) * | 1996-10-07 | 1999-06-16 | Uriach & Cia Sa J | Procedimiento para la preparacion de la 8-cloro-6, 11-dihidro-11-(1-(5-metil-3-piridinil)metil)-4-piperidinilideno)-5h-benzo(5,6) ciclohepta (1,2-b)piridina. |
US5783705A (en) * | 1997-04-28 | 1998-07-21 | Texas Biotechnology Corporation | Process of preparing alkali metal salys of hydrophobic sulfonamides |
ES2241133T3 (es) | 1997-04-28 | 2005-10-16 | Encysive Pharmaceuticals Inc. | Sulfamidas para el tratamiento de los trastornos inducidos por la endotelina. |
JP2001519428A (ja) * | 1997-10-10 | 2001-10-23 | シェーリング コーポレイション | エチル4−(8−クロロ−5,6−ジヒドロ−11H−ベンゾ[5,6]シクロヘプタ[1,2−b]ピリジン−11−イリデン)−1−ピペリデンカルボキシレート多形物 |
WO2001045668A2 (en) * | 1999-12-20 | 2001-06-28 | Schering Corporation | Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
SK287105B6 (sk) * | 1999-12-20 | 2009-12-07 | Schering Corporation | Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním |
US7405223B2 (en) | 2000-02-03 | 2008-07-29 | Schering Corporation | Treating allergic and inflammatory conditions |
AU2001284320A1 (en) * | 2000-08-29 | 2002-03-13 | Ranbaxy Laboratories Limited | Process for the synthesis of n-(5-methylnicotinoyl)-4-hydroxypiperidine, a key intermediate of rupatadine |
WO2004080461A2 (en) * | 2003-03-12 | 2004-09-23 | TEVA Gyógyszergyár Részvénytársaság | Stable pharmaceutical compositions of desloratadine |
JP3881640B2 (ja) * | 2003-08-08 | 2007-02-14 | 塩野義製薬株式会社 | ロラタジンを含むドライシロップ剤 |
US20090197907A1 (en) * | 2005-04-01 | 2009-08-06 | Hetero Drugs Limited | Novel crystalline form of rupatadine free base |
WO2006114676A2 (en) * | 2005-04-27 | 2006-11-02 | Cadila Pharmaceuticals Limited | A process for the preparation of rupatadine |
US20070036859A1 (en) * | 2005-08-11 | 2007-02-15 | Perry Ronald L | Sustained release antihistamine and decongestant composition |
CN101497606B (zh) * | 2008-01-29 | 2014-04-02 | 东莞达信生物技术有限公司 | 卢帕他定或其盐的制备方法 |
BR112012028919B1 (pt) * | 2010-06-30 | 2021-11-09 | J. Uriach Y Compañia S.A. | Sal da rupatadina como um agente anti-histamínico |
PT2402012E (pt) | 2010-06-30 | 2013-02-25 | Uriach Y Compania S A J | Formulações líquidas de fumarato de rupatadina |
CN103619839B (zh) * | 2011-06-28 | 2016-06-01 | 福建省闽东力捷迅药业有限公司 | 抗-变态反应的苯并环庚并噻吩衍生物 |
CN102653535A (zh) * | 2011-12-09 | 2012-09-05 | 东莞达信生物技术有限公司 | 卢帕他定游离碱及其制取方法 |
ES2572533T3 (es) | 2013-07-09 | 2016-06-01 | Cadila Pharmaceuticals Limited | Un proceso mejorado para la preparación de fumarato de rupatadina |
US10463656B2 (en) | 2017-01-05 | 2019-11-05 | Iowa State University Research Foundation, Inc. | Methods and compositions for prevention of feedlot bovine respiratory disease |
TWI825013B (zh) | 2017-04-19 | 2023-12-11 | 日商帝國製藥股份有限公司 | 含有盧帕他定(rupatadine)之貼附劑 |
CN109096251B (zh) * | 2018-09-26 | 2020-11-03 | 合肥医工医药股份有限公司 | 具有组胺受体双重拮抗活性的化合物及用途 |
CN109734702B (zh) * | 2019-03-01 | 2020-07-03 | 南京工业大学 | 一种采用微通道反应装置制备富马酸卢帕他定的方法 |
WO2021086133A1 (ko) * | 2019-10-31 | 2021-05-06 | (주)제이디바이오사이언스 | 삼환식 화합물 및 이의 약학적 용도 |
JP2023549381A (ja) | 2020-11-18 | 2023-11-24 | バイオファーマ・シナジーズ,エス.エル. | 抗ヒスタミン活性化合物を含む口内分散性粉末組成物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4282233B1 (en) * | 1980-06-19 | 2000-09-05 | Schering Corp | Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines |
AU570306B2 (en) * | 1984-02-15 | 1988-03-10 | Schering Corporation | 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridine and its salts. |
US4826853A (en) * | 1986-10-31 | 1989-05-02 | Schering Corporation | 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use |
US5089496A (en) * | 1986-10-31 | 1992-02-18 | Schering Corporation | Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies |
WO1989010363A1 (en) * | 1988-04-28 | 1989-11-02 | Schering Corporation | Fused polycyclic compounds, compositions, methods of manufacture and their use as paf antagonists, antihistamines and/or antiinflammatory agents |
CA2004211A1 (en) * | 1988-11-30 | 1990-05-31 | Masataka Syoji | Piperidine derivatives and hyportensives containing the same |
IL98572A (en) * | 1990-06-22 | 1995-07-31 | Schering Corp | Bite-benzo or benzopyrido compounds Cyclohepta piperidine, piperidylidene and piperazine, preparations and methods of use. |
GB9102997D0 (en) * | 1991-02-13 | 1991-03-27 | Pfizer Ltd | Therapeutic agents |
US5360907A (en) * | 1993-06-14 | 1994-11-01 | G.D. Searle & Co. | Pyrrolo[3,2-B]pyridinylalkyl benzamide derivatives |
-
1992
- 1992-05-22 ES ES09201054A patent/ES2042421B1/es not_active Expired - Fee Related
-
1993
- 1993-05-14 CA CA002096318A patent/CA2096318C/en not_active Expired - Lifetime
- 1993-05-17 US US08/061,720 patent/US5407941A/en not_active Expired - Lifetime
- 1993-05-19 DE DE122008000031C patent/DE122008000031I2/de active Active
- 1993-05-19 ES ES93108177T patent/ES2076817T3/es not_active Expired - Lifetime
- 1993-05-19 JP JP5117427A patent/JP2730612B2/ja not_active Expired - Lifetime
- 1993-05-19 DE DE69300255T patent/DE69300255T2/de not_active Expired - Lifetime
- 1993-05-19 AT AT93108177T patent/ATE124939T1/de active
- 1993-05-19 EP EP93108177A patent/EP0577957B1/de not_active Expired - Lifetime
- 1993-05-19 DK DK93108177.2T patent/DK0577957T3/da active
- 1993-05-20 MX MX9302958A patent/MX9302958A/es unknown
- 1993-05-21 KR KR1019930008812A patent/KR0156518B1/ko not_active IP Right Cessation
-
1995
- 1995-02-21 US US08/391,702 patent/US5476856A/en not_active Expired - Lifetime
-
1998
- 1998-06-16 HK HK98105341A patent/HK1006169A1/xx not_active IP Right Cessation
-
2004
- 2004-11-03 LU LU91121C patent/LU91121I2/fr unknown
-
2009
- 2009-04-07 NL NL300384C patent/NL300384I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
LU91121I2 (fr) | 2005-01-03 |
DK0577957T3 (da) | 1995-12-04 |
KR0156518B1 (ko) | 1998-11-16 |
NL300384I1 (nl) | 2009-06-02 |
DE122008000031I2 (de) | 2010-12-30 |
KR930023359A (ko) | 1993-12-18 |
US5407941A (en) | 1995-04-18 |
CA2096318A1 (en) | 1993-11-23 |
DE69300255T2 (de) | 1996-01-04 |
ES2076817T3 (es) | 1995-11-01 |
EP0577957B1 (de) | 1995-07-12 |
CA2096318C (en) | 1998-06-23 |
NL300384I2 (nl) | 2009-08-03 |
DE69300255D1 (de) | 1995-08-17 |
JPH0687856A (ja) | 1994-03-29 |
ATE124939T1 (de) | 1995-07-15 |
ES2042421B1 (es) | 1994-08-01 |
JP2730612B2 (ja) | 1998-03-25 |
EP0577957A1 (de) | 1994-01-12 |
US5476856A (en) | 1995-12-19 |
ES2042421A1 (es) | 1993-12-01 |
HK1006169A1 (en) | 1999-02-12 |
MX9302958A (es) | 1993-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE122008000031I1 (de) | 8-Chlor-11-[1-[(5-methyl-3-pyridyl)-methyl]-4-piperidyliden]-6,11-dihydro-5H-benzol[5,6]cyclohepta[1,2-b]-pyridin | |
NL300042I2 (nl) | 8-Chloor-6,11-dihydro-11-(4-piperidylideen)-5H-benzoÄ5,6ÜcyclohepataÄ1,2-bÜpyridine en de zouten daarvan, werkwijzen voor de produktie daarvan en farmaceutische composities, die deze verbindingen bevatten. | |
NZ234476A (en) | Paf antagonist thienodiazepine derivatives; intermediates, pharmaceutical compositions and preparatory processes | |
NZ240378A (en) | Substituted thiazolidinedione derivatives; pharmaceutical compositions, | |
IE812420L (en) | Spiro compounds | |
WO1992014696A3 (en) | SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES | |
IE872839L (en) | Benzocycloheptapyridines | |
HU9202889D0 (en) | Method for producing new n-substituted heterocyclic compounds as well as pharmaceutical preparatives containing them | |
NO305025B1 (no) | FremgangsmÕte for fremstilling av piperidinderivater | |
AU1549500A (en) | Use of n-substituted azaheterocyclic compounds for the manufacture of a pharmaceutical composition for the treatment of indications related to angiogenesis | |
HU9402462D0 (en) | Process for the preparation of 0-[4-(4-piperidinyl)butyl]-tyrosine derivatives as fibrinogen receptor antagonists | |
EG19361A (en) | A process for the preparation of piperidine compound having local anaesthetica and analgetic | |
ES2087818A1 (es) | 8-cloro-11-(1-((5-metil-3-piridil)metil)-4-piperidiliden)-6,11-dihidro-5h-benzo-(5,6)cicloheptal(1,2-b)piridina, fumarato. | |
NO20005485D0 (no) | Orale preparater inneholdende 8-klor-6,11-dihydro-11-(4- piperyliden)-5H-benzo-[5,6]syklohepta[1,2-b]pyridin | |
GB9323162D0 (en) | 4-(1h-2-methylimidazo(4,5-c)pyridinylmethyl)phenylsulphonamid e derivatives as antagonists of paf | |
HU906010D0 (en) | New substituted alkyl-piperidine derivatives | |
FI905225A0 (fi) | Menetelmä 1-//1-/2-(trifluorimetyyli)-4-pyrimidinyyli/-4-piperidinyyli/metyyli/-2-pyrrolidinonin valmistamiseksi suuressa mittakaavassa | |
FR2696745B1 (fr) | Procédé de préparation de dérivés de phényltétrazole. | |
ES2087026A1 (es) | Nuevo derivado de la benzo(5,6)ciclohepta- (1.2-b) piridina. | |
NO177640C (no) | Analogifremgangsmåte til fremstilling av terapeutisk aktive 4-substituerte alkylkarbapenemforbindelser | |
HU9204112D0 (en) | Method for producing new benzole derivatives condensed with 5-member ring as well as pharmaceutical preparatives containing these compounds | |
HU9201206D0 (en) | 5,7-dihydroxi-2-methyl-8-[4-(3-hydroxi-1-(1-propyl)-piperidinyl]-4h-1-benzopyrane-4-one derivatives as well as methods for producing said compounds and pharmaceutical preparatives containing them | |
HU9500962D0 (en) | Process for the preparation of substituted, nitrogen containing heterocyclic compounds | |
NO178064C (no) | Fremgangsmåte til fremstilling av 5-amino-1-(hydroksymetyl)cyklopentan-1,2,3,4-tetraol | |
FI963354A0 (fi) | Menetelmä piperidiinijohdannaisten valmistamiseksi |